Molecular Partners : Annual General Meeting Minutes
Minutes of the 19th Annual General Meeting of the Shareholders of MOLECULAR PARTNERS AG, held at 9:00 a.m. on 17 April 2024 at JED Events, Zürcherstrasse 39,...
Source: marketscreener.com
Agneteb Fredriksen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Agneteb Fredriksen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Agneteb Fredriksen Today - Breaking & Trending Today
Nykode Therapeutics announces first subject dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate
First subject dosed with Nykode Therapeutics' T cell focused SARS-CoV-2 vaccine candidate. This is part of the ongoing phase 1/2 two-arm clinical trial VB-D-01 designed to specifically address emerging
Source: finanznachrichten.de
Investegate |Nykode Therapeutics Announcements | Nykode Therapeutics: Nykode Therapeutics announces first subject dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate
Investegate announcements from Nykode Therapeutics, Nykode Therapeutics announces first subject dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate
Source: investegate.co.uk
Nykode Therapeutics announces first subject dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Nykode Therapeutics (Formerly Vaccibody*)) Enters Into Multi-target License and Collaboration Agreement With Regeneron to Develop Innovative Vaccines Against Cancer and Infectious Diseases
Multi-target agreement covers five programs focused on off-the-shelf vaccines for cancer and infectious disease Nykode Therapeutics (formerly Vaccibody) to receive an upfront payment of USD
Source: finanznachrichten.de